

Author: Smith Mathew Omidi Yadollah Gumbleton Mark
Publisher: Informa Healthcare
ISSN: 1061-186X
Source: Journal of Drug Targeting, Vol.15, Iss.4, 2007-05, pp. : 253-268
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


By Visser Corine C. Stevanović Sanja Heleen Voorwinden L. Gaillard Pieter J. Crommelin Daan J.A. Danhof Meindert de Boer Albertus G.
Journal of Drug Targeting, Vol. 12, Iss. 3, 2004-04 ,pp. :




European Journal of Pharmaceutics and Biopharmaceutics, Vol. 52, Iss. 1, 2001-07 ,pp. :

